These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 10457531)
61. Impact of 5-HT Chaumont-Dubel S; Galant S; Prieur M; Bouschet T; Bockaert J; Marin P Cells; 2023 Jan; 12(3):. PubMed ID: 36766768 [TBL] [Abstract][Full Text] [Related]
62. Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice. Żmudzka E; Lustyk K; Sałaciak K; Siwek A; Jaśkowska J; Kołaczkowski M; Sapa J; Pytka K Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986498 [TBL] [Abstract][Full Text] [Related]
63. Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes. Vitalis T; Ansorge MS; Dayer AG Front Cell Neurosci; 2013; 7():93. PubMed ID: 23801939 [TBL] [Abstract][Full Text] [Related]
64. [5-HT Doly S; Martin PY; Courteix C Med Sci (Paris); 2021 May; 37(5):547-549. PubMed ID: 34003104 [No Abstract] [Full Text] [Related]
65. 5-HT6 receptors and Alzheimer's disease. Ramírez MJ Alzheimers Res Ther; 2013; 5(2):15. PubMed ID: 23607787 [TBL] [Abstract][Full Text] [Related]
66. Physical and Functional Interaction between 5-HT Kim SH; Seo M; Hwang H; Moon DM; Son GH; Kim K; Rhim H Exp Neurobiol; 2019 Feb; 28(1):17-29. PubMed ID: 30853821 [TBL] [Abstract][Full Text] [Related]
67. Serotonin, neural markers, and memory. Meneses A Front Pharmacol; 2015; 6():143. PubMed ID: 26257650 [TBL] [Abstract][Full Text] [Related]
68. Benzenesulfonyl and Benzenesulfonamide as Modulators of the 5-HT6 Receptor: Patent Highlight. Rosse G ACS Med Chem Lett; 2012 Nov; 3(11):881-2. PubMed ID: 24900400 [No Abstract] [Full Text] [Related]
69. Distribution of serotonin receptor of type 6 (5-HT₆) in human brain post-mortem. A pharmacology, autoradiography and immunohistochemistry study. Marazziti D; Baroni S; Pirone A; Giannaccini G; Betti L; Schmid L; Vatteroni E; Palego L; Borsini F; Bordi F; Piano I; Gargini C; Castagna M; Catena-Dell'osso M; Lucacchini A Neurochem Res; 2012 May; 37(5):920-7. PubMed ID: 22278721 [TBL] [Abstract][Full Text] [Related]
70. The role of the striatum in compulsive behavior in intact and orbitofrontal-cortex-lesioned rats: possible involvement of the serotonergic system. Schilman EA; Klavir O; Winter C; Sohr R; Joel D Neuropsychopharmacology; 2010 Mar; 35(4):1026-39. PubMed ID: 20072118 [TBL] [Abstract][Full Text] [Related]
71. Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat. Marcos B; Chuang TT; Gil-Bea FJ; Ramirez MJ Br J Pharmacol; 2008 Oct; 155(3):434-40. PubMed ID: 18622410 [TBL] [Abstract][Full Text] [Related]
72. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Ciranna L Curr Neuropharmacol; 2006 Apr; 4(2):101-14. PubMed ID: 18615128 [TBL] [Abstract][Full Text] [Related]
73. Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries. Nakamura K CNS Drug Rev; 2002; 8(1):70-89. PubMed ID: 12070527 [TBL] [Abstract][Full Text] [Related]